Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Worcester Polytechnic Institute Receives $1.94 Million NIH Grant for Cardiac Regeneration Research
  • USA - English


News provided by

Worcester Polytechnic Institute

Aug 28, 2013, 18:00 ET

Share this article

Share toX

Share this article

Share toX

Professors Pins (left) and Gaudette at an automated microthread extruder built at WPI
Professors Pins (left) and Gaudette at an automated microthread extruder built at WPI

Worcester, MA (PRWEB) August 28, 2013 -- The National Institutes of Health (NIH) has awarded a five-year, $1.94 million grant to a biomedical research team at Worcester Polytechnic Institute (WPI) working at the forefront of cell therapies for healing cardiac muscle damaged by heart attack or chronic disease.

Funded through the NIH's premiere Research Project Grant (R01) program, the project will be led by Glenn Gaudette, PhD, associate professor of biomedical engineering at WPI, working in close collaboration with George Pins, PhD, associate professor of biomedical engineering at WPI, and Michael Laflamme, MD, PhD, associate professor of pathology at the University of Washington.

"We are grateful for the support of the National Institutes of Health and we hope that this intensive program of research will advance cell therapies for people who suffer from heart disease," Gaudette said.

The multifaceted research program funded by the NIH grant is based on the use of biopolymer microthreads to deliver adult stem cells into damaged hearts to promote muscle regeneration. The microthreads, each about the width of a human hair, can be braided into cable-like structures that mimic natural connective tissues. First developed in Pins's lab as a potential tool for repairing torn anterior cruciate ligaments (ACL) in the knee, the microthreads were transformed by Gaudette and Pins into biological sutures that can be used to stitch stem cells directly into wound sites and damaged tissues.

During a heart attack, vessels that deliver blood and oxygen to the heart are choked off, damaging sections of cardiac muscle. The damaged or "infarcted" muscle scars over and becomes rigid and unable to contract, diminishing the heart's ability to pump blood. The ultimate goal of Gaudette’s team is to use the regenerative capabilities of adult stem cells to transform portions of that scarred tissue back into working heart muscle.

"Earning this gold-standard, competitive award from the National Institutes of Health is a wonderful affirmation of the work Professors Gaudette and Pins are doing, and the importance of the collaborative model of research our faculty are pursuing," said WPI Provost Eric Overström, PhD. "Over the past 10 years, WPI has invested strategically in life sciences and bioengineering programs because the convergence of biology and engineering will enable a range of new therapies and medical devices that will improve human health."

Earlier studies by Gaudette and others have shown that when human mesenchymal stem cells (hMSCs), which are derived from bone marrow, are implanted in damaged hearts, they moderately improve cardiac function. The main limitation of these studies was getting large numbers of hMSCs to engraft into the damaged heart tissue. The methods used at the time—injecting the cells into the bloodstream or directly into the heart muscle—yielded very low results, with 15 percent or less of the cells injected actually surviving and attaching to the heart muscle. Most cells were washed away by the bloodstream.

To improve cell delivery, Gaudette and Pins developed the microthread technology as a provisional "scaffold" or a temporary structure to carry the cells into the damaged heart tissue. In early studies, the WPI team was able to grow up to 40,000 adult stem cells on each centimeter of a microthread suture. When the microthreads were stitched into an infarcted rat heart, more than 60 percent of the cells successfully engrafted into the cardiac muscle.

Over the next five years, the team will work to improve the technology in several ways in hopes of pushing cardiac cell therapy closer to human trials. "Congratulations to WPI, as well as Professors Gaudette and Pins, on receiving this NIH grant," said Massachusetts Congressman Jim McGovern. "WPI has a well-deserved reputation as a hub for national biomedical collaborations and cutting-edge advances, and this award is testament to the brilliant work being done there day in and day out."

Through the new grant, the research team will attempt to optimize the adhesion of stem cells to the microthreads by adjusting the composition of the threads and the process used to grow cells on the threads. They will use two different types of cells: hMSCs and induced pluripotent stem cells (iPSCs), which are adult human skin cells reprogrammed to act like stem cells.

They will evaluate the ability of each cell type to engraft and promote regeneration in an infarcted rat heart. The iPSCs will be developed in the Laflamme laboratory and cultured in a way that promotes their differentiation into heart muscle cells known as cardiomyocytes. "UW Medicine's Michael Laflamme is a leader in the field of using induced pluripotent stem cells for cardiac regeneration and we are thrilled to be working with him and the team at the University of Washington," Gaudette said.

After stitching the cells into the damaged hearts, the team will use novel imaging and analytic techniques to determine whether the cells are promoting muscle regeneration and improving the mechanical function of the infarcted heart. Finally, the team will add another class of cells, one that promotes blood vessel formation, to the microthreads to see if it, in combination with the stem cells, can augment the regeneration of the damaged cardiac muscle.

"This is a great example of translational research that combines biomedical engineering expertise with advanced stem cell biology" said Michael Manning, PhD, associate provost for research ad interim at WPI. "By bringing these teams together through collaborative research, we accelerate the development of clinical solutions."

About Worcester Polytechnic Institute

Founded in 1865 in Worcester, Mass., WPI is one of the nation's first engineering and technology universities. Its 14 academic departments offer more than 50 undergraduate and graduate degree programs in science, engineering, technology, business, the social sciences, and the humanities and arts, leading to bachelor’s, master’s and doctoral degrees. WPI's talented faculty work with students on interdisciplinary research that seeks solutions to important and socially relevant problems in fields as diverse as the life sciences and bioengineering, energy, information security, materials processing, and robotics. Students also have the opportunity to make a difference to communities and organizations around the world through the university's innovative Global Perspective Program. There are more than 30 WPI project centers throughout North America and Central America, Africa, Australia, Asia, and Europe.

Contact:
Michael Cohen
Worcester Polytechnic Institute
Worcester, Massachusetts
508-868-4778, mcohen(at)wpi(dot)edu

Michael Cohen, Worcester Polytechnic Institute, http://www.wpi.edu, +1 (508) 868-4778, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.